Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...

The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic ...

Chennai: In a meaningful step towards transforming liver cancer care in India, Apollo Proton Cancer Centre (APCC), Chennai, ...

The University of Hong Kong’s Faculty of Medicine said on Thursday that one of its 41 drugs under clinical trials for Hepatitis B may provide a cure ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...

Patients may have to wait from 30 days to over five years to receive a liver for transplant in the U.S. Of the over 11,600 ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...